Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
J Mol Diagn ; 18(2): 205-14, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26752307

ABSTRACT

Personalized medicine has gained increasing importance in clinical oncology, and several clinically important biomarkers are implemented in routine practice. In an effort to guarantee high quality of molecular testing in France, three subsequent external quality assessment rounds were organized at the initiative of the National Cancer Institute between 2012 and 2014. The schemes included clinically relevant biomarkers for metastatic colorectal (KRAS, NRAS, BRAF, PIK3CA, microsatellite instability) and non-small cell lung cancer (EGFR, KRAS, BRAF, PIK3CA, ERBB2), and they represent the first multigene/multicancer studies throughout Europe. In total, 56 laboratories coordinated by 28 regional molecular centers participated in the schemes. Laboratories received formalin-fixed, paraffin-embedded samples and were asked to use routine methods for molecular testing to predict patient response to targeted therapies. They were encouraged to return results within 14 calendar days after sample receipt. Both genotyping and reporting were evaluated separately. During the three external quality assessment rounds, mean genotype scores were all above the preset standard of 90% for all biomarkers. Participants were mainly challenged in case of rare insertions or deletions. Assessment of the written reports showed substantial progress between the external quality assessment schemes on multiple criteria. Several essential elements such as the clinical interpretation of test results and the reason for testing still require improvement by continued external quality assessment education.


Subject(s)
Carcinoma, Non-Small-Cell Lung/genetics , Colorectal Neoplasms/genetics , Laboratory Proficiency Testing/standards , Lung Neoplasms/genetics , Carcinoma, Non-Small-Cell Lung/pathology , Colorectal Neoplasms/pathology , France , Genetic Testing/standards , Genotyping Techniques/standards , Humans , Lung Neoplasms/pathology , Microsatellite Instability , Time Factors
2.
Eur Respir J ; 46(1): 207-18, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25929957

ABSTRACT

Anaplastic lymphoma kinase (ALK) gene rearrangements in lung adenocarcinoma result in kinase activity targetable by crizotinib. Although fluorescence in situ hybridisation (FISH) is the reference diagnostic technique, immunohistochemistry (IHC) could be useful for pre-screening. Diagnostic yields of ALK IHC, FISH and quantitative reverse transcriptase PCR performed in 14 French pathology/molecular genetics platforms were compared. 547 lung adenocarcinoma specimens were analysed using 5A4 and D5F3 antibodies, two break-apart FISH probes and TaqMan kits. Clinicopathological data were recorded. 140 tumours were ALK rearranged (FISH with ≥15% of rearranged cells) and 400 were ALK FISH negative (<15%). FISH was not interpretable for seven cases. ALK patients were young (p=0.003), mostly females (p=0.007) and light/nonsmokers (p<0.0001). 13 cases were IHC negative but FISH ≥15%, including six cases with FISH between 15% and 20%; eight were IHC positive with FISH between 10% and 14%. Sensitivity and specificity for 5A4 and D5F3 were 87% and 92%, and 89% and 76%, respectively. False-negative IHC, observed in 2.4% of cases, dropped to 1.3% for FISH >20%. Variants were undetected in 36% of ALK tumours. Discordances predominated with FISH ranging from 10% to 20% of rearranged cells and were centre dependent. IHC remains a reliable pre-screening method for ALK rearrangement detection.


Subject(s)
Adenocarcinoma/genetics , Gene Rearrangement , Lung Neoplasms/genetics , Pyrazoles/therapeutic use , Pyridines/therapeutic use , Receptor Protein-Tyrosine Kinases/genetics , Adenocarcinoma of Lung , Adolescent , Adult , Aged , Aged, 80 and over , Anaplastic Lymphoma Kinase , Crizotinib , False Negative Reactions , Female , France , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Young Adult
3.
Virchows Arch ; 462(6): 619-32, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23639973

ABSTRACT

Retinoid receptors (RRs) play a key role in cell proliferation and differentiation. We characterized the expression of RA receptors and retinoid X receptors (RARs and RXRs) in a series of 111 thyroid tumors and investigated the mechanisms responsible for their deregulation: hypermethylation of the RARB2 promoter, loss of heterozygosity (LOH) in the regions of RARB and RXRA, and altered expression of CRBP1 and enzymes involved in RA biosynthesis (RDH10 and RALDH2). Expression of RALDH2 and RDH10 was conserved in 100 % of adenomas and in 90 and 98 %, respectively, of carcinomas, whereas staining for CRBP1 was decreased in 9 % of FAs and 28 % of carcinomas, mainly anaplastic carcinomas (55 %). We found an abnormal expression of RARA, RARB, RXRA, and RXRB in 67, 69, 66, and 73 %, respectively, of thyroid carcinomas (n = 78) and in 9, 9, 9, and 33 % of follicular adenomas (n = 33) (p < 0.001). An abnormal staining pattern of at least two of these markers had 90 % sensitivity and 91 % specificity for a diagnosis of malignancy. Promoter hypermethylation of RARB2 was observed in some anaplastic carcinomas (14 %). LOH was found to be common at the RARB locus (3p24-3p25) and the RXRA locus (9q34), respectively, in 44 and 55 % of carcinomas and in 27 and 43 % of adenomas. In conclusion, immunohistochemical staining for RARs and RXRs may help in the differential diagnosis between well-differentiated carcinoma and follicular adenoma. Further investigation should be carried out to determine whether the characterization of RR expression might identify patients who could benefit from therapy with RA derivatives.


Subject(s)
Adenocarcinoma/diagnosis , Adenoma/diagnosis , Biomarkers, Tumor/metabolism , Retinoid X Receptors/metabolism , Thyroid Neoplasms/diagnosis , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adenoma/genetics , Adenoma/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Alcohol Oxidoreductases/genetics , Alcohol Oxidoreductases/metabolism , Aldehyde Dehydrogenase 1 Family , Biomarkers, Tumor/genetics , Child , Diagnosis, Differential , Female , Gene Expression Regulation, Neoplastic , Gene Silencing , Humans , Loss of Heterozygosity , Male , Methylation , Middle Aged , Receptors, Retinoic Acid/genetics , Receptors, Retinoic Acid/metabolism , Retinal Dehydrogenase/genetics , Retinal Dehydrogenase/metabolism , Retinoid X Receptors/genetics , Retinol-Binding Proteins, Cellular/genetics , Retinol-Binding Proteins, Cellular/metabolism , Sensitivity and Specificity , Thyroid Neoplasms/genetics , Thyroid Neoplasms/metabolism , Young Adult
4.
Ann Pathol ; 29(6): 460-7, 2009 Dec.
Article in French | MEDLINE | ID: mdl-20005432

ABSTRACT

The quest for formaldehyde substitutes is motivated by two fundamental developments: the OSHA regulation standard declaring it hazardous and advocating its substitution with less dangerous chemicals and the fact that formalin is a poor preserver of nucleic acids. Among the non-alcoholic formalin substitute, glyoxal has been hailed as the best alternative. In this work, we showed that glyoxal-containing fixatives are not plausible polyvalent substitution options.


Subject(s)
Formaldehyde/analogs & derivatives , Glyoxal/chemistry , Preservatives, Pharmaceutical/standards , Disinfectants , Fixatives , Nucleic Acids/chemistry , Tissue Fixation/standards , United States , United States Occupational Safety and Health Administration/legislation & jurisprudence
5.
Ann Pathol ; 26(1): 8-21, 2006 Feb.
Article in French | MEDLINE | ID: mdl-16841005

ABSTRACT

The scientific usefulness of the molecular data obtained from tissue analysis is related directly to the quality of the tissue specimen. The most ideal tissue specimen is the one that carries a complete and unaltered representation of the tissue in vivo. The aim of this review is to provide an overview of the effects of fixation and tissue processing on the content and integrity of nucleic acid and proteins.


Subject(s)
DNA/analysis , Fixatives , Pathology/methods , Proteins/analysis , RNA/analysis , Cryopreservation , Freeze Drying , Humans , Lymph Nodes/pathology , Molecular Biology/methods
6.
Mod Pathol ; 17(9): 1087-96, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15143340

ABSTRACT

Persistent polyclonal B-cell lymphocytosis is usually reported in young smoking women. Whether this syndrome represents a premalignant or benign disease remains unclear. Indeed, because of the association of Bcl-2/IgH rearrangement and cytogenetic abnormalities, such cases may be misdiagnosed as the leukemic phase of a non-Hodgkin's lymphoma. We report eight new cases of persistent polyclonal B-cell lymphocytosis, which displayed a misleading bone marrow histological pattern, that is, intravascular B-cell infiltrate, constantly associated with Bcl-2 immunohistostaining, as seen in some lymphoma. We also show the absence or low expression of adhesion molecules on persistent polyclonal B-cell lymphocytes, suggesting that migration abnormalities might lead to bone marrow and peripheral blood accumulation. Although most cases presented multiple Bcl-2/IgH gene rearrangements and appeared to be polyclonal, oligoclonal expansion was identified in one out of eight patients, yet was not associated with clinical aggressiveness. The occasional reports of oligoclonal IgH and Bcl-2/IgH rearrangements in this disorder suggest that polyclonal expansion may be followed by the emergence of a predominant clone. However, the benign clinical course and lack of biological evolution in most cases imply that it is mandatory to distinguish this disorder from other malignant lymphoproliferations, so that unnecessary aggressive therapy can be avoided.


Subject(s)
B-Lymphocytes/pathology , Bone Marrow/pathology , Lymphocytosis/pathology , Adult , Antigens, CD/analysis , B-Lymphocytes/metabolism , Blood Vessels/metabolism , Blood Vessels/pathology , Bone Marrow/blood supply , Bone Marrow/metabolism , Cytogenetic Analysis , Female , Gene Rearrangement , Humans , Immunoglobulin Heavy Chains/genetics , Immunophenotyping , Karyotyping , Lymphocytosis/genetics , Lymphocytosis/metabolism , Male , Middle Aged , Polymerase Chain Reaction , Proto-Oncogene Proteins c-bcl-2/genetics , Receptors, Antigen, T-Cell, gamma-delta/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...